Eric has over 30 years of clinical research experience. He started his career in 1983 as head trial department of the Comprehensive Cancer Center Amsterdam. Between 1990 and 2007 he has held several positions at companies specialized in clinical research including NDDO Oncology, , where he acted as COO and CEO. After acquisition of NDDO Oncology by INC Research in 2005 Eric became Vice President Oncology for Europe of INC Research. Eric is one of the co-founders of SMS-oncology, a specialized oncology CRO established in 2007 where he worked as COO and CEO. In 2013 he became partner at Aglaia. Eric is director at Modra Pharmaceuticals and non-executive director at Mimetas, both are Aglaia portfolio companies.